ANXA1 and neoplasm: Emerging evidence from tumor microenvironments further demonstrates that ANXA1 modulates the maturation of dendritic cells and macrophages, leading to reduced T cell activation and immune evasion (Zhang et al., 2024c; Jiang et al., 2025).